Induction Healthcare Group PLC Appointment of acting Head of Product/Development
24 Ottobre 2019 - 11:00AM
RNS Non-Regulatory
TIDMINHC
Induction Healthcare Group PLC
24 October 2019
24 October 2019
Induction Healthcare Group PLC
("Induction", the "Company" or the "Group")
Appointment of Dr Hugo Stephenson as acting Head of
Product/Development
Induction Healthcare Group PLC, a leading healthcare technology
company helping to streamline the delivery of care, announces that,
to cover for ill health, Dr. Hugo Stephenson, Non-Executive
Director, has taken up the role of interim Head of
Product/Development.
Hugo is a technology entrepreneur and a practicing doctor in
Australia. He is co-founder of Induction Healthcare and has a
combination of healthcare and technology experience including as
executive chairman and co-founder of DrugDev and Vice President at
Quintiles.
The Board has approved this temporary management change to
ensure continued effective operational performance pending the
leadership of product/development being fulfilled internally or
externally in relation to which a process is already underway.
-Ends-
ENQUIRIES
Induction Healthcare Group PLC via FTI Consulting
Ibs Mahmood, Chief Executive Officer
Numis Securities (Nominated Adviser and
Broker)
James Black / Freddie Barnfield / Huw Jeremy
/ Matthew Jones +44 (0) 207 260 1000
FTI Consulting
Brett Pollard / Jamie Ricketts / Elena
Kalinskaya / Sam Purewal +44 (0) 203 727 1000
About Induction
Induction Healthcare Group PLC is a leading healthcare
technology company focused on helping healthcare professionals to
streamline the delivery of care. The Group's technology enables
healthcare professionals to save time and deliver care more
effectively and to identify ways to allocate resources more
efficiently.
The Group is initially targeting improving the way healthcare
professionals communicate with each other through its Induction
Switch app that provides a telephone directory (allowing healthcare
professionals to easily find extension telephone numbers),
messaging and an administration portal (to share and view hospital
guidelines), all in a secure and regulatory compliant setting.
As at 19 September 2019, the Induction Switch app had registered
users surpassing 100,000, most of which are UK hospital
doctors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAEAKEDAFFNFFF
(END) Dow Jones Newswires
October 24, 2019 05:00 ET (09:00 GMT)
Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Induction Healthcare (LSE:INHC)
Storico
Da Mar 2023 a Mar 2024